7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Hemarthrosis D006395 1 associated lipids
Cherubism D002636 1 associated lipids
Arthropathy, Neurogenic D001177 1 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Mandibular Injuries D008338 1 associated lipids
Diabetic Foot D017719 1 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Spondylarthropathies D025242 1 associated lipids
Emphysema D004646 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Widschwendter M et al. Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers. 2015 EBioMedicine pmid:26629528
Silva Vde O et al. β-Glucans (Saccharomyces cereviseae) Reduce Glucose Levels and Attenuate Alveolar Bone Loss in Diabetic Rats with Periodontal Disease. 2015 PLoS ONE pmid:26291983
Darabi H et al. Adiponectin as a Protective Factor Against the Progression Toward Type 2 Diabetes Mellitus in Postmenopausal Women. 2015 Medicine (Baltimore) pmid:26287420
Rzepka R et al. Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor. 2015 BMC Pregnancy Childbirth pmid:26059227
Weichhaus M et al. Osteoprotegerin in breast cancer: beyond bone remodeling. 2015 Mol. Cancer pmid:26054853
Kastritis E et al. Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging. 2015 Blood Cancer J pmid:26047389
Qiao B et al. Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma. 2015 Drug Des Devel Ther pmid:25733814
Choe CH et al. Transmembrane protein 173 inhibits RANKL-induced osteoclast differentiation. 2015 FEBS Lett. pmid:25728277
Kuroyanagi G et al. Resveratrol amplifies BMP-4-stimulated osteoprotegerin synthesis via p38 MAP kinase in osteoblasts. 2015 Mol Med Rep pmid:26044505
Lee CJ et al. Serum osteoprotegerin is associated with arterial stiffness assessed according to the cardio-ankle vascular index in hypertensive patients. 2015 J. Atheroscler. Thromb. pmid:25318352

Table of Content